To develop local skills, build scientific innovation and promote quality manufacturingAstraZeneca announced its decision of further investing $ 90 million over the next 5 years in India. The announcement was made following a meeting between the company's Executive Vice President for International Region - Leon Wang and Prime Minister of India, Narendra Modi, during the latter's visit to Sweden, where the two countries signed a joint declaration on innovation partnership for a sustainable future.
This investment commitment will span across AstraZeneca's diverse footprint in India with an aim to strengthen its manufacturing, clinical operations, patient safety & regulatory science, IT services and commercial operations. Furthermore this investment will support scientific data generation, quality manufacturing, science talent development and collaborative development of innovative solutions to improve the standard of care of non-communicable diseases in India.
Powered by Capital Market - Live News
(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)